ReviewMolecular and clinical oncology2013

Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.